We are hosting a discussion on the CDMO Industry with Rahul Singhv who is a global leader in the Life Sciences industry and serves as the Chief Executive Officer of National Resilience, Inc., a business he co-founded in 2020. Resilience is building the most advanced biopharmaceutical manufacturing for the production of cutting-edge medicines like cell and gene therapies, viral vectors, vaccines and proteins. During our call we will discuss the current supply and demand dynamics for CDMO’s, long term supply/demand forecasts, outlook for end various end markets such as cell and gene therapies, viral vectors, and vaccines, how to interpret the impact of FDA issues 483’s, as well as his large public CDMO’s including Catalent, Lonza, Pfizer and Thermo Fisher among other topics.
An investor presented a CTLT Long Idea in late June as well.